These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pyrimidine pathways in health and disease. Löffler M; Fairbanks LD; Zameitat E; Marinaki AM; Simmonds HA Trends Mol Med; 2005 Sep; 11(9):430-7. PubMed ID: 16098809 [TBL] [Abstract][Full Text] [Related]
6. beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. van Kuilenburg AB; Meinsma R; Beke E; Assmann B; Ribes A; Lorente I; Busch R; Mayatepek E; Abeling NG; van Cruchten A; Stroomer AE; van Lenthe H; Zoetekouw L; Kulik W; Hoffmann GF; Voit T; Wevers RA; Rutsch F; van Gennip AH Hum Mol Genet; 2004 Nov; 13(22):2793-801. PubMed ID: 15385443 [TBL] [Abstract][Full Text] [Related]
7. Neurological presentations of inborn errors of purine and pyrimidine metabolism. Nassogne MC; Marie S; Dewulf JP Eur J Paediatr Neurol; 2024 Jan; 48():69-77. PubMed ID: 38056117 [TBL] [Abstract][Full Text] [Related]
8. Specific mutations in transmembrane helix 8 of human concentrative Na+/nucleoside cotransporter hCNT1 affect permeant selectivity and cation coupling. Slugoski MD; Loewen SK; Ng AM; Smith KM; Yao SY; Karpinski E; Cass CE; Baldwin SA; Young JD Biochemistry; 2007 Feb; 46(6):1684-93. PubMed ID: 17279631 [TBL] [Abstract][Full Text] [Related]
9. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Hyde RJ; Karpinski E; Cass CE; Baldwin SA; Young JD Mol Membr Biol; 2001; 18(1):65-72. PubMed ID: 11396613 [TBL] [Abstract][Full Text] [Related]
10. ß-ureidopropionase deficiency: phenotype, genotype and protein structural consequences in 16 patients. van Kuilenburg AB; Dobritzsch D; Meijer J; Krumpel M; Selim LA; Rashed MS; Assmann B; Meinsma R; Lohkamp B; Ito T; Abeling NG; Saito K; Eto K; Smitka M; Engvall M; Zhang C; Xu W; Zoetekouw L; Hennekam RC Biochim Biophys Acta; 2012 Jul; 1822(7):1096-108. PubMed ID: 22525402 [TBL] [Abstract][Full Text] [Related]
11. Conserved residues F316 and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitivity and membrane expression, respectively. Lai Y; Lee EW; Ton CC; Vijay S; Zhang H; Unadkat JD Am J Physiol Cell Physiol; 2005 Jan; 288(1):C39-45. PubMed ID: 15456697 [TBL] [Abstract][Full Text] [Related]
12. Novel developments in metabolic disorders of purine and pyrimidine metabolism and therapeutic applications of their analogs. Torres RJ; Peters GJ; Puig JG Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):165-73. PubMed ID: 24940665 [TBL] [Abstract][Full Text] [Related]
14. Fatal immune dysregulation due to a gain of glycosylation mutation in lymphocyte perforin. Chia J; Thia K; Brennan AJ; Little M; Williams B; Lopez JA; Trapani JA; Voskoboinik I Blood; 2012 Feb; 119(7):1713-6. PubMed ID: 22186995 [TBL] [Abstract][Full Text] [Related]
15. Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis. Jurecka A; Tylki-Szymanska A Mol Genet Metab; 2022 Jul; 136(3):164-176. PubMed ID: 35216884 [TBL] [Abstract][Full Text] [Related]
17. Advances in purine and pyrimidine metabolism in health and diseases. Hirano M; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):495-501. PubMed ID: 27906626 [TBL] [Abstract][Full Text] [Related]
18. Inborn errors of purine and pyrimidine metabolism. Jurecka A J Inherit Metab Dis; 2009 Apr; 32(2):247-63. PubMed ID: 19291420 [TBL] [Abstract][Full Text] [Related]
19. Pyrimidine metabolism in man. Smith LH N Engl J Med; 1973 Apr; 288(15):764-71. PubMed ID: 4143960 [No Abstract] [Full Text] [Related]